赛诺医疗涨2.00%，成交额3045.69万元，主力资金净流入5.67万元

Group 1 - The core viewpoint of the news is that Sino Medical has shown significant stock performance with an 82.89% increase year-to-date, despite recent declines in the short term [1] - As of December 19, the stock price reached 17.85 CNY per share, with a market capitalization of 7.426 billion CNY [1] - The company has experienced a net inflow of main funds amounting to 56,700 CNY, with large orders accounting for 13.22% of total buying and 13.03% of total selling [1] Group 2 - Sino Medical operates in the pharmaceutical and biological industry, specifically in medical devices and consumables, with a focus on high-end interventional medical devices [2] - The company reported a revenue of 364 million CNY for the first nine months of 2025, reflecting a year-on-year growth of 14.24%, and a net profit of 21.118 million CNY, which is a 293.46% increase [2] - The number of shareholders increased by 164.74% to 29,400 as of September 30, while the average circulating shares per person decreased by 62.23% to 14,170 shares [2] Group 3 - Sino Medical has distributed a total of 41 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3]